Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia

Background: Although telomere length maintenance is a common characteristic of hematological malignancies, the role of telomere length as a prognostic factor to stratify acute lymphoblastic leukemia (ALL) patients depending on their risk of relapse remains elusive. Methods: This knowledge gap motiva...

全面介紹

書目詳細資料
發表在:Life
Main Authors: Elena Vakonaki, Iordanis Pelagiadis, Stella Baliou, Manolis N. Tzatzarakis, Athanasios Alegakis, Ioanna Lygerou, Persefoni Fragkiadaki, Maria Stratigaki, Nikolaos Katzilakis, Aristidis Tsatsakis, Eftichia Stiakaki
格式: Article
語言:英语
出版: MDPI AG 2025-10-01
主題:
在線閱讀:https://www.mdpi.com/2075-1729/15/10/1537
_version_ 1848667987388661760
author Elena Vakonaki
Iordanis Pelagiadis
Stella Baliou
Manolis N. Tzatzarakis
Athanasios Alegakis
Ioanna Lygerou
Persefoni Fragkiadaki
Maria Stratigaki
Nikolaos Katzilakis
Aristidis Tsatsakis
Eftichia Stiakaki
author_facet Elena Vakonaki
Iordanis Pelagiadis
Stella Baliou
Manolis N. Tzatzarakis
Athanasios Alegakis
Ioanna Lygerou
Persefoni Fragkiadaki
Maria Stratigaki
Nikolaos Katzilakis
Aristidis Tsatsakis
Eftichia Stiakaki
author_sort Elena Vakonaki
collection DOAJ
container_title Life
description Background: Although telomere length maintenance is a common characteristic of hematological malignancies, the role of telomere length as a prognostic factor to stratify acute lymphoblastic leukemia (ALL) patients depending on their risk of relapse remains elusive. Methods: This knowledge gap motivated us to examine telomere length values in children with ALL at the time of diagnosis and after treatment using quantitative polymerase chain reaction (qPCR) (<i>n</i> = 35). To achieve high-resolution precision and cell specificity, a quantitative fluorescence in situ hybridization (qFISH) technique was developed (<i>n</i> = 5). Results: The results demonstrated statistically significant evidence of telomere shortening in the lymphoblasts of children with ALL but not in the lymphocytes of children after remission following treatment. Our findings also suggested a significant association between telomere shortening and a high risk of relapse disease. Last but not least, our preliminary results showed a trend that telomere shortening was more pronounced in children with B-ALL compared to those with T-ALL in a non-significant manner. Conclusions: Consequently, the current study provides preliminary insights into the potentially substantial prognostic value of telomere length in the progression of pediatric ALL, with the possibility of predicting treatment response. To clarify the application of telomere length as a possible biomarker for disease progression and treatment response in children with ALL, the telomere length values of additional participants need to be examined in further studies.
format Article
id doaj-art-e2e11aef6d4f43c288dcaeaca1f1e40d
institution Directory of Open Access Journals
issn 2075-1729
language English
publishDate 2025-10-01
publisher MDPI AG
record_format Article
spelling doaj-art-e2e11aef6d4f43c288dcaeaca1f1e40d2025-10-28T16:48:40ZengMDPI AGLife2075-17292025-10-011510153710.3390/life15101537Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic LeukemiaElena Vakonaki0Iordanis Pelagiadis1Stella Baliou2Manolis N. Tzatzarakis3Athanasios Alegakis4Ioanna Lygerou5Persefoni Fragkiadaki6Maria Stratigaki7Nikolaos Katzilakis8Aristidis Tsatsakis9Eftichia Stiakaki10Laboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceDepartment of Pediatric Hematology-Oncology and Autologous Hematopoietic Stem Cell Transplanta-tion Unit, University Hospital of Heraklion and Laboratory of Blood Diseases and Childhood Cancer Bi-ology, School of Medicine, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceBackground: Although telomere length maintenance is a common characteristic of hematological malignancies, the role of telomere length as a prognostic factor to stratify acute lymphoblastic leukemia (ALL) patients depending on their risk of relapse remains elusive. Methods: This knowledge gap motivated us to examine telomere length values in children with ALL at the time of diagnosis and after treatment using quantitative polymerase chain reaction (qPCR) (<i>n</i> = 35). To achieve high-resolution precision and cell specificity, a quantitative fluorescence in situ hybridization (qFISH) technique was developed (<i>n</i> = 5). Results: The results demonstrated statistically significant evidence of telomere shortening in the lymphoblasts of children with ALL but not in the lymphocytes of children after remission following treatment. Our findings also suggested a significant association between telomere shortening and a high risk of relapse disease. Last but not least, our preliminary results showed a trend that telomere shortening was more pronounced in children with B-ALL compared to those with T-ALL in a non-significant manner. Conclusions: Consequently, the current study provides preliminary insights into the potentially substantial prognostic value of telomere length in the progression of pediatric ALL, with the possibility of predicting treatment response. To clarify the application of telomere length as a possible biomarker for disease progression and treatment response in children with ALL, the telomere length values of additional participants need to be examined in further studies.https://www.mdpi.com/2075-1729/15/10/1537acute lymphoblastic leukemia (ALL)childhoodtelomere length
spellingShingle Elena Vakonaki
Iordanis Pelagiadis
Stella Baliou
Manolis N. Tzatzarakis
Athanasios Alegakis
Ioanna Lygerou
Persefoni Fragkiadaki
Maria Stratigaki
Nikolaos Katzilakis
Aristidis Tsatsakis
Eftichia Stiakaki
Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
acute lymphoblastic leukemia (ALL)
childhood
telomere length
title Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
title_full Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
title_fullStr Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
title_full_unstemmed Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
title_short Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
title_sort insights into the prognostic value of telomere length in childhood acute lymphoblastic leukemia
topic acute lymphoblastic leukemia (ALL)
childhood
telomere length
url https://www.mdpi.com/2075-1729/15/10/1537
work_keys_str_mv AT elenavakonaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT iordanispelagiadis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT stellabaliou insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT manolisntzatzarakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT athanasiosalegakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT ioannalygerou insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT persefonifragkiadaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT mariastratigaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT nikolaoskatzilakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT aristidistsatsakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia
AT eftichiastiakaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia